Connect with us

Health

GlobalData reports bright future for allergy testing market, with 20 IVD devices in development: ET HealthWorld

Published

on

Future of allergy testing market looks bright, with 20 IVD devices in pipeline: GlobalData, ET HealthWorld

London: With the arrival of spring bringing warmer weather and seasonal allergies, millions around the world are experiencing the onset of allergy symptoms. Pollen levels have been on the rise due to various factors like climate changes, vegetation patterns, and urban development. The advancement of precision medicine and personalized medical approaches has led to a better understanding of allergic reactions and the most effective treatments for patients. GlobalData reports a positive outlook for the allergy testing market with 20 in vitro diagnostic (IVD) devices in development and two undergoing clinical trials.

According to GlobalData, there are currently 58 immunoglobulin E (IgE) allergy blood in vitro diagnostic (IVD) devices available in the market. These devices include multi-parameter tests that can detect over 200 different allergens. Such tests are efficient, minimally invasive, and provide patients with valuable information about the causes of their allergies.

Selena Yu, a Senior Medical Analyst at GlobalData, highlighted the growing interest in healthcare plans post-COVID-19, leading to a rise in proactive patient behavior. Allergy tests, particularly for seasonal, food, and environmental allergies, offer valuable insights to patients seeking to understand and manage their allergies better. As changes in diets and environments continue to impact allergy incidences, the need for accurate and comprehensive allergy testing becomes more critical.

Companies like Thermo Fisher Scientific are offering advanced allergy tests like ImmunoCAP IgE, which can detect over 500 allergens and allergen mixes. These tests not only save time and costs for patients and healthcare providers but also enable faster and more specific treatment plans. The shift towards blood-based tests instead of traditional prick tests has made allergy testing more accessible and comfortable for patients, especially children with severe allergic reactions. The increasing popularity of minimally invasive tests indicates a positive trend for allergy testing in diverse populations.

Click to comment

You must be logged in to post a comment Login

Leave a Reply

Trending